NCT04564768

Brief Summary

The overall objective of this project is to explore the feasibility, acceptability and potential effects of the online MBCR program in gynecological cancer settings. This will provide preliminary efficacy data in prevision of a larger, confirmatory, randomized controlled trial. As this study will be one of the first led in a French speaking country and the first conducted in a university hospital environment in Switzerland, the investigators would like to investigate the early implementation of this program among professionals and patients. Furthermore, they will investigate if in the online MBCR group, participants will show improvement in psychosocial outcomes, consumption of psychotropic and opioid medication, spirituality and meaning in life and in different biological processes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 19, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 22, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 25, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

November 29, 2022

Status Verified

November 1, 2022

Enrollment Period

2.5 years

First QC Date

August 22, 2020

Last Update Submit

November 28, 2022

Conditions

Keywords

Online Mindfulness-Based Cancer Recovery

Outcome Measures

Primary Outcomes (1)

  • Participants' attendance to the program

    Number of overall sessions attended - patients are expected to attend at least 5 of the 10 sessions planned (including the 6-h retreat)

    Within 3 weeks of completion of the intervention

Secondary Outcomes (27)

  • Acceptability of the program (quantitative)

    Every week during the intervention and within 3 weeks of completion of the intervention

  • Acceptability of the program (qualitative)

    Every week during the intervention and within 3 weeks of completion of the intervention

  • Appropriateness of the program (quantitative)

    Within 3 weeks of completion of the intervention

  • Appropriateness of the program (qualitative)

    Within 3 weeks of completion of the intervention

  • Fidelity of the program

    Within 3 weeks of completion of the intervention

  • +22 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Online Mindfulness-Based Cancer Recovery

Behavioral: Online Mindfulness-Based Cancer Recovery (MBCR)

Control group

NO INTERVENTION

Treatment as usual

Interventions

Mindfulness-Based Cancer Recovery (MBCR) is a standardized group program which focuses primarily on the challenges faced by people living with cancer. It is an 8-week program consisting of weekly group meetings of 1.5 to 2 hours. Home practice of 45 minutes per day (15 min yoga; 30 min meditation) is prescribed. As the weeks progress, different forms of meditation are introduced, beginning with a body scan sensory awareness experience, progressing to sitting and walking meditations. Gentle Hatha yoga is incorporated throughout, as a form of moving meditation. Didactic instruction as well as group discussion and reflection, problem solving and skillful inquiry are commonly applied teaching tools.

Intervention group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 18 years
  • Being a woman
  • Being diagnosed with breast or any gynecological cancer (either ovarian, cervical, vulvar, womb or vaginal cancer), stages I to IV.
  • For women with localized cancers: having completed all adjuvant treatments, such as surgery, chemotherapy and/or radiotherapy, at least 3 months previously, with the exception of hormonal, immune and targeted therapy,
  • For women with metastatic cancers: having a performance status \< 3, not undergoing IV chemotherapy and having a life expectancy more than 9 months as estimated by their treating oncologist.
  • Free from acute infection for 2 weeks before biochemical assessment.
  • Speaking and reading French fluently
  • Be able to follow the online course via a computer/tablet

You may not qualify if:

  • Inability to follow the procedures of the study due to:
  • Significant deafness
  • Physical impairment that prevents attending the sessions
  • Mental retardation (ICD-10)
  • Dementia (ICD-10)
  • Depression (ICD-10) \*
  • Spectrum disorder of schizophrenia (ICD-10) \*\*
  • Alcohol or other substance dependence (ICD-10) \*\*
  • Emotionally labile personality disorder that is incompatible with group participation (ICD-10) \*\*
  • A post-traumatic stress disorder (PTSD) (ICD-10)\*\*
  • Currently engages in meditation one or more times per week
  • Previous participation in an MBI program
  • Serious physiological illnesses that would interfere with the interpretation of biochemical data (e.g., anemia, diabetes, cardiovascular diseases, blood cancers, inflammatory bowel diseases, autoimmune diseases, asthma being treated with steroids, immunodeficiency)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hôpitaux Universitaires de Genève (HUG)

Geneva, Switzerland

Location

Centre Hospitalier Universitaire Vaudois (CHUV)

Lausanne, Switzerland

Location

Related Publications (1)

  • Gaignard ME, Martin D, Stanic J, Hilfiker R, Bodmer A, Ljuslin M, Zaman K, Labidi-Galy I, Sarivalasis A, Carlson LE, Peters S, Dietrich PY, Eicher M, Bondolfi G, Jermann F. The Experience of Women With Breast or Gynecological Cancer After Participation in an Online Mindfulness-Based Cancer Recovery (e-MBCR) Program: Secondary Outcomes Analysis of a Pilot Mixed Methods Randomized Controlled Trial. Psychooncology. 2025 Nov;34(11):e70334. doi: 10.1002/pon.70334.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A randomized controlled pilot study including qualitative and quantitative elements.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 22, 2020

First Posted

September 25, 2020

Study Start

December 19, 2019

Primary Completion

June 30, 2022

Study Completion

September 30, 2022

Last Updated

November 29, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations